inclusion criteria: 1. volunteers who have understood all the procedures to be applied within the scope of the study protocol and gave their consent. 2. patients between 18-60 years old. 3. patients whose symptoms and complaints associated with covid-19 started within 48 hours. 4. mild cases whose treatment to be given as outpatient. 1. although asymptomatic, patients with high crp (\> 20 mg/l) and/or lymphopenia (\<1000/mm3) 2. patients with symptoms such as fever, muscle/joint pain, cough, sore throat, nasal congestion, loss of smell. 3. patients without serious underlying diseases (cardiovascular diseases, diabetes mellitus, hypertension, cancer, chronic lung diseases, immunosuppressive conditions) 4. patients with normal chest x-ray and / or chest tomography (no sign of pneumonia) 5. patients who accept oropharyngeal sample and venous blood collection at regular intervals within the scope of the protocol. 6. patients who were not involved in any other interventional study.

inclusion criteria: 1. volunteers who have understood all the procedures to be applied within the scope of the study protocol and gave their consent. 2. patients between 18-60 years old. 3. patients whose symptoms and complaints associated with covid-19 started within 48 hours. 4. mild cases whose treatment to be given as outpatient. 1. although asymptomatic, patients with high crp (\> 20 mg/l) and/or lymphopenia (\<1000/mm3) 2. patients with symptoms such as fever, muscle/joint pain, cough, sore throat, nasal congestion, loss of smell. 3. patients without serious underlying diseases (cardiovascular diseases, diabetes mellitus, hypertension, cancer, chronic lung diseases, immunosuppressive conditions) 4. patients with normal chest x-ray and / or chest tomography (no sign of pneumonia) 5. patients who accept oropharyngeal sample and venous blood collection at regular intervals within the scope of the protocol. 6. patients who were not involved in any other interventional study.

inclusion criteria: volunteers who have understood all the procedures to be applied within the scope of the study protocol and gave their consent. patients between 18-60 years old. patients whose symptoms and complaints associated with covid-19 started within 48 hours. mild cases whose treatment to be given as outpatient. although asymptomatic, patients with high crp (> 20 mg/l) and/or lymphopenia (<1000/mm3) patients with symptoms such as fever, muscle/joint pain, cough, sore throat, nasal congestion, loss of smell. patients without serious underlying diseases (cardiovascular diseases, diabetes mellitus, hypertension, cancer, chronic lung diseases, immunosuppressive conditions) patients with normal chest x-ray and / or chest tomography (no sign of pneumonia) patients who accept oropharyngeal sample and venous blood collection at regular intervals within the scope of the protocol. patients who were not involved in any other interventional study.

inclusion criteria: volunteers who have understood all the procedures to be applied within the scope of the study protocol and gave their consent. patients between 18-60 years old. patients whose symptoms and complaints associated with covid-19 started within 48 hours. mild cases whose treatment to be given as outpatient. although asymptomatic, patients with high crp (> 20 mg/l) and/or lymphopenia (<1000/mm3) patients with symptoms such as fever, muscle/joint pain, cough, sore throat, nasal congestion, loss of smell. patients without serious underlying diseases (cardiovascular diseases, diabetes mellitus, hypertension, cancer, chronic lung diseases, immunosuppressive conditions) patients with normal chest x-ray and / or chest tomography (no sign of pneumonia) patients who accept oropharyngeal sample and venous blood collection at regular intervals within the scope of the protocol. patients who were not involved in any other interventional study.

inclusion criteria: 1. volunteers who have understood all the procedures to be applied within the scope of the study protocol and gave their consent. 2. patients between 18-60 years old. 3. patients whose symptoms and complaints associated with covid-19 started within 48 hours. 4. mild cases whose treatment to be given as outpatient. 1. although asymptomatic, patients with high crp (> 20 mg/l) and/or lymphopenia (<1000/mm3) 2. patients with symptoms such as fever, muscle/joint pain, cough, sore throat, nasal congestion, loss of smell. 3. patients without serious underlying diseases (cardiovascular diseases, diabetes mellitus, hypertension, cancer, chronic lung diseases, immunosuppressive conditions) 4. patients with normal chest x-ray and / or chest tomography (no sign of pneumonia) 5. patients who accept oropharyngeal sample and venous blood collection at regular intervals within the scope of the protocol. 6. patients who were not involved in any other interventional study.

inclusion criteria: 1. volunteers who have understood all the procedures to be applied within the scope of the study protocol and gave their consent. 2. patients between 18-60 years old. 3. patients whose symptoms and complaints associated with covid-19 started within 48 hours. 4. mild cases whose treatment to be given as outpatient. 1. although asymptomatic, patients with high crp (> 20 mg/l) and/or lymphopenia (<1000/mm3) 2. patients with symptoms such as fever, muscle/joint pain, cough, sore throat, nasal congestion, loss of smell. 3. patients without serious underlying diseases (cardiovascular diseases, diabetes mellitus, hypertension, cancer, chronic lung diseases, immunosuppressive conditions) 4. patients with normal chest x-ray and / or chest tomography (no sign of pneumonia) 5. patients who accept oropharyngeal sample and venous blood collection at regular intervals within the scope of the protocol. 6. patients who were not involved in any other interventional study.